文献速递神经肿瘤脊柱脊髓外科

单次分割脊柱立体定向消融体部放疗联合容积旋转调强技术

Single fraction spine stereotactic ablative body radiotherapy with volumetric modulated arc therapy.
PubMed 文献 · J Neurooncol · 2017-04-13

本研究回顾单中心2010至2014年使用容积旋转调强(VMAT)实施脊柱立体定向消融体部放疗(SABR)治疗椎体转移瘤的经验:73例患者共95个病灶接受治疗,多数(79%)为单次20 Gy。中位随访12.7个月时临床局部控制率为97%(92/95),主观疼痛评分平均下降81%,77%患者镇痛药用量减少,69%(66/95)治疗部位疼痛完全缓解。作者认为该方案在临床局部控制和姑息治疗方面有效。

要点

  • 单次20 Gy为多数(79%)患者的剂量,正常组织受限时降为18 Gy(11%)或16 Gy(8%)。
  • 中位随访12.7个月时临床局部控制率为97%(92/95)。
  • 疼痛完全缓解见于69%(66/95)患者,77%患者镇痛药用量减少。

核心结论

  • 作者认为使用VMAT技术的SABR方案在实现临床局部控制和姑息治疗方面临床有效。
  • 本文为首次报告VMAT引导SABR临床结局的发表。

研究设计与样本

  • 单中心经验研究,2010至2014年73例患者共95个脊柱转移病灶接受VMAT引导的SABR治疗。
  • 采用临床局部控制、疼痛程度和类固醇药物使用评估治疗反应。

主要发现

  • 中位随访12.7个月(均值18.0,范围1-56个月)时临床局部控制率为97%(92/95)。
  • 主观疼痛评分平均下降81%(中位100%,范围28-100%)。
  • 77%患者麻醉性镇痛药用量减少,69%(66/95)患者治疗部位疼痛完全缓解。
  • 治疗前33%(31/95)患者存在肿瘤硬膜外延伸;其中45%(14/31)治疗前有神经功能损害,23%(7/31)发生脊髓压迫。
  • 治疗前34例患者存在某种神经功能损害,其中24%(8/34)运动功能改善,其余76%(26/34)神经功能障碍稳定。

关键数值与推荐

  • 多数(79%)患者接受单次20 Gy剂量。
  • 正常组织约束无法满足时剂量降至单次18 Gy(11%)或16 Gy(8%)。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

This study investigated a single institution's experience with volumetric modulated arc therapy (VMAT) directed stereotactic ablative body radiotherapy (SABR) for vertebral metastases. From 2010 to 2014, 95 lesions of spinal metastases in 73 patients were treated with SABR using VMAT. Clinical local control, pain level, and use of steroid medication were employed to evaluate treatment responses. The majority (79%) of patients were treated with a radiation dose of 20 Gy in a single fraction. However, when normal tissue constraints could not be achieved, the dose was reduced to 18 Gy (11%) or 16 Gy (8%) in 1 fraction. At the median follow up of 12.7 months (mean 18.0, range 1-56 months), clinical local control was 97% (92 out of 95). There was a mean 81% (median 100%, range 28-100%) decrease in subjective pain score. Seventy-seven percent of patients had a decrease in narcotic pain medication use. Pain was completely resolved at the treatment site for 69% (66/95) of patients. Prior to the SABR treatment, 33% (31/95) of patients had epidural extension of tumor. Among patients with epidural involvement, 45% (14/31) exhibited neurologic impairment prior to treatment. Twenty-three percent (7/31) experienced spinal cord compression. Prior to treatment, 34 patients experienced some form of neurologic impairment. Of these patients, 24% (8/34) experienced improved motor functioning; the remaining 76% (26/34) of patients' neurological dysfunction were stable. Our results indicate the SABR regimen using VMAT technique is clinically effective in achieving clinical local control and palliation. This is the first publication reporting clinical outcomes of VMAT directed SABR.

来源:J Neurooncol,查看原文。版权归原作者所有。

引用

  1. Gestaut MM, Thawani N, Kim S, et al. Single fraction spine stereotactic ablative body radiotherapy with volumetric modulated arc therapy. J Neurooncol. 2017. PMID: 28409420. doi:10.1007/s11060-017-2428-6

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。